David Chan Bodin Siebert

Statistics

Publications

Citations

132

H-Index

Active since

2016

Affiliations

Medical University of Vienna(Current)

TU Wien

David Chan Bodin Siebert is an author at Medical University of Vienna specializing in pharmacology, receptor pharmacology, and receptor-ligand interactions.

ORCID

Publications per year

2016–2019

Publications

Different Benzodiazepines Bind with Distinct Binding Modes to GABAAReceptors

Alshaimaa A. Elgarf, David Chan Bodin Siebert, Friederike Steudle et al. · ACS Chemical Biology · 2018 · 40 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes

Xenia Simeone, David Chan Bodin Siebert, Konstantina Bampali et al. · Scientific Reports · 2017 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Towards functional selectivity for α6β3γ2 GABAA receptors: a series of novel pyrazoloquinolinones

Marco Treven, David Chan Bodin Siebert, Raphael Holzinger et al. · British Journal of Pharmacology · 2017 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors

Ghamdan Beshr, Roman Sommer, Dirk Hauck et al. · MedChemComm · 2016 · 24 citations

Life Sciences, Microbiology, Pharmacology +13

Defined concatenated α6α1β3γ2 GABAA receptor constructs reveal dual action of pyrazoloquinolinone allosteric modulators

Xenia Simeone, M.T. Iorio, David Chan Bodin Siebert et al. · Bioorganic & Medicinal Chemistry · 2019 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

1–5 of 5